Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7217)
All Articles published online
|
Publishing Process of This Article
|
Apr 7, 2014 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sansone S, Guarino M, Castiglione F, Rispo A, Auriemma F, Loperto I, Rea M, Caporaso N, Morisco F. Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease. World J Gastroenterol 2014; 20(13): 3516-3524 [PMID: 24707134 DOI: 10.3748/wjg.v20.i13.3516] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i13/3516.htm |
| Number | Citing Articles |
| 1 |
Marco Canzoni, Massimo Marignani, Maria Laura Sorgi, Paola Begini, Michela Ileen Biondo, Sara Caporuscio, Vincenzo Colonna, Francesca Della Casa, Paola Conigliaro, Cinzia Marrese, Eleonora Celletti, Irene Modesto, Mario Stefano Peragallo, Bruno Laganà, Andrea Picchianti-Diamanti, Roberta Di Rosa, Claudia Ferlito, Simonetta Salemi, Raffaele D’Amelio, Tommaso Stroffolini. Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in Italy. Microorganisms 2020; 8(11): 1792 doi: 10.3390/microorganisms8111792
|
| 2 |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
|
| 3 |
Maria Guarino, Marco Picardi, Anna Vitiello, Novella Pugliese, Matilde Rea, Valentina Cossiga, Fabrizio Pane, Nicola Caporaso, Filomena Morisco. Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma. Annals of Hepatology 2017; 16(2): 198 doi: 10.5604/16652681.1231579
|
| 4 |
Giuseppe Losurdo, Andrea Iannone, Antonella Contaldo, Michele Barone, Enzo Ierardi, Alfredo Di Leo, Mariabeatrice Principi. Chronic Viral Hepatitis in a Cohort of Inflammatory Bowel Disease Patients from Southern Italy: A Case-Control Study. Pathogens 2020; 9(11): 870 doi: 10.3390/pathogens9110870
|
| 5 |
Igor Snast, Lihi Atzmony, Marius Braun, Emmilia Hodak, Lev Pavlovsky. Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature. Journal of the American Academy of Dermatology 2017; 77(1): 88 doi: 10.1016/j.jaad.2017.01.037
|
| 6 |
Julie J. Hong, Edward K. Hadeler, Megan L. Mosca, Nicholas D. Brownstone, Tina Bhutani, Wilson J. Liao. TNF-Alpha Inhibitors and Ustekinumab for the Treatment of Psoriasis: Therapeutic Utility in the Era of IL-17 and IL-23 Inhibitors. Journal of Psoriasis and Psoriatic Arthritis 2022; 7(2): 79 doi: 10.1177/24755303211047479
|
| 7 |
Nicola Imperatore, Fabiana Castiglione, Antonio Rispo, Anna Sessa, Nicola Caporaso, Filomena Morisco. Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00867
|
| 8 |
Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar, Sunil Kasturi, Amrit Gopan, Sridhar Sundaram, Aditya Kale. Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis. Intestinal Research 2023; 21(3): 392 doi: 10.5217/ir.2022.00094
|
| 9 |
Pilar López-Serrano, Elsa de la Fuente Briongos, Elisa Carrera Alonso, Jose Lázaro Pérez-Calle, Conrado Fernández Rodríguez. Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy. World Journal of Hepatology 2015; 7(3): 539-547 doi: 10.4254/wjh.v7.i3.539
|
| 10 |
Shivani B. Kaushik, Mark G. Lebwohl. Psoriasis: Which therapy for which patient. Journal of the American Academy of Dermatology 2019; 80(1): 43 doi: 10.1016/j.jaad.2018.06.056
|
| 11 |
Jing Fang, Wenge Li, Xiangxin Peng, Zhao Tan, Min Tan, Cong Zhang, Wenbo Wang, Zhihong Xu, Gumin Zhou. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis. International Urology and Nephrology 2017; 49(3): 475 doi: 10.1007/s11255-016-1487-5
|
| 12 |
Marco Fiore, Sebastiano Leone, Alberto Enrico Maraolo, Emilio Berti, Giovanni Damiani. Liver Illness and Psoriatic Patients. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3140983
|
| 13 |
Wei Huang, Lingyao Du, Hong Tang. Hepatitis B Virus Reactivation: Overview and Management. Future Virology 2021; 16(12): 821 doi: 10.2217/fvl-2021-0275
|
| 14 |
Claudio Bonifati, Viviana Lora, Dario Graceffa, Lorenzo Nosotti. Management of psoriasis patients with hepatitis B or hepatitis C virus infection. World Journal of Gastroenterology 2016; 22(28): 6444-6455 doi: 10.3748/wjg.v22.i28.6444
|
| 15 |
Martin Feuchtenberger, Arne Schäfer, Axel Philipp Nigg, Michael Rupert Kraus. Hepatitis B Serology in Patients with Rheumatic Diseases. The Open Rheumatology Journal 2016; 10(1): 39 doi: 10.2174/1874312901610010039
|
| 16 |
Vlad Alexandru Ionescu, Gina Gheorghe, Valentin Nicolae Varlas, Ana Maria Alexandra Stanescu, Camelia Cristina Diaconu. Hepatobiliary Impairments in Patients with Inflammatory Bowel Diseases: The Current Approach. Gastroenterology Insights 2022; 14(1): 13 doi: 10.3390/gastroent14010002
|
| 17 |
Cassandra Michelle Skinner-Taylor, Alejandro Erhard-Ramírez, Mario Alberto Garza-Elizondo, Jorge Antonio Esquivel-Valerio, Carlos Abud-Mendoza, Marco Ulises Martínez-Martínez, David Vega-Morales, Ana Arana-Guajardo. Are RA patients from a non-endemic HCV population screened for HCV? A cross-sectional analysis of three different settings. Reumatología Clínica (English Edition) 2017; 13(3): 156 doi: 10.1016/j.reumae.2016.03.016
|
| 18 |
Paulina Núñez F, Fabiola Castro, Gabriel Mezzano, Rodrigo Quera, Diego Diaz, Lorena Castro. Hepatobiliary manifestations in inflammatory bowel disease: A practical approach. World Journal of Hepatology 2022; 14(2): 319-337 doi: 10.4254/wjh.v14.i2.319
|
| 19 |
Toru Ogura, Chihiro Shiraishi. Efficacy of Prednisone Avoidance in Patients With Liver Transplant Using the U.S. Food and Drug Administration Adverse Event Reporting System. Cureus 2024; doi: 10.7759/cureus.60193
|
| 20 |
Cem Cekic, Fatih Aslan, Adnan Kirci, Zeynep Zehra Gümüs, Mahmut Arabul, Elif Sartas Yüksel, Sezgin Vatansever, Süreyya Gül Yurtsever, Emrah Alper, Belks Ünsal. Evaluation of Factors Associated With Response to Hepatitis B Vaccination in Patients With Inflammatory Bowel Disease. Medicine 2015; 94(22): e940 doi: 10.1097/MD.0000000000000940
|
| 21 |
Cassandra Michelle Skinner-Taylor, Alejandro Erhard-Ramírez, Mario Alberto Garza-Elizondo, Jorge Antonio Esquivel-Valerio, Carlos Abud-Mendoza, Marco Ulises Martínez-Martínez, David Vega-Morales, Ana Arana-Guajardo. Are RA patients from a non-endemic HCV population screened for HCV? A cross-sectional analysis of three different settings. Reumatología Clínica 2017; 13(3): 156 doi: 10.1016/j.reuma.2016.03.006
|
| 22 |
Mao-Xin Huang, Cai-Yun Wang, Jin-Yan Guo, Jian-Hao Li, Xiao-Hong Li, Jiang-An Zhang, Jian-Bin Yu. Pharmacotherapy for Behçet’s Disease and the Risk of Malignancy. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.661150
|
| 23 |
Giuseppe Losurdo, Irene Vita Brescia, Chiara Lillo, Martino Mezzapesa, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo, Maria Rendina. Liver involvement in inflammatory bowel disease: What should the clinician know?. World Journal of Hepatology 2021; 13(11): 1534-1551 doi: 10.4254/wjh.v13.i11.1534
|
| 24 |
E‐Poster Presentations ‐ A4) Lower GI. Journal of Gastroenterology and Hepatology 2017; 32(S3): 106 doi: 10.1111/jgh.13877
|
| 25 |
Niloofar Khoshnam-Rad, Homayoon Vahedi, Anahita Sadeghi, Mansoor Rastegarpanah, Soha Namazi, Amir Anushiravani, Ali Reza Sima, Shabnam Shahrokh, Sudabeh Alatab, Reza Malekzadeh. Iranian Consensus Guideline for Pharmacotherapy with Biologics and Small Molecules Drugs in Adults with Inflammatory Bowel Diseases. Middle East Journal of Digestive Diseases 2023; 15(2): 83 doi: 10.34172/mejdd.2023.327
|
| 26 |
Livia Biancone, Vito Annese, Sandro Ardizzone, Alessandro Armuzzi, Emma Calabrese, Flavio Caprioli, Fabiana Castiglione, Michele Comberlato, Mario Cottone, Silvio Danese, Marco Daperno, Renata D’Incà, Giuseppe Frieri, Walter Fries, Paolo Gionchetti, Anna Kohn, Giovanni Latella, Monica Milla, Ambrogio Orlando, Claudio Papi, Carmelina Petruzziello, Gabriele Riegler, Fernando Rizzello, Simone Saibeni, Maria Lia Scribano, Maurizio Vecchi, Piero Vernia, Gianmichele Meucci, Annalisa Aratari, Fabrizio Bossa, Maria Cappello, Andrea Cassinotti, Alberto Chiriatti, Gionata Fiorino, Vincenzo Formica, Luisa Guidi, Alessandra Losco, Filippo Mocciaro, Sara Onali, Luca Pastorelli, Roberta Pica, Mariabeatrice Principi, Sara Renna, Chiara Ricci, Antonio Rispo, Francesca Rogai, Loredana Sarmati, Franco Scaldaferri, Luisa Spina, Rosy Tambasco, Anna Testa, Angelo Viscido. Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Digestive and Liver Disease 2017; 49(4): 338 doi: 10.1016/j.dld.2017.01.141
|
| 27 |
Jing Fang, Wenge Li, Min Tan, Xiangxin Peng, Zhao Tan, Wenbo Wang. Effect of different hepatitis B infection status on the prognosis of active lupus nephritis treated with immunosuppression: a retrospective analysis of 177 patients. International Journal of Rheumatic Diseases 2018; 21(5): 1060 doi: 10.1111/1756-185X.13313
|
| 28 |
Mortada HF El-Shabrawi, Sara Tarek, Maha Abou-Zekri, Safa Meshaal, Afaf Enayet, Engy Adel Mogahed. Hepatobiliary manifestations in children with inflammatory bowel disease: A single-center experience in a low/middle income country. World Journal of Gastrointestinal Pharmacology and Therapeutics 2020; 11(3): 48-58 doi: 10.4292/wjgpt.v11.i3.48
|
| 29 |
Filomena Morisco, Maria Guarino, Serena La Bella, Luisa Di Costanzo, Nicola Caporaso, Fabio Ayala, Nicola Balato. Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis. BMC Gastroenterology 2014; 14(1) doi: 10.1186/s12876-014-0214-x
|
| 30 |
Sara Massironi, Lorena Pirola, Giacomo Mulinacci, Antonio Ciaccio, Chiara Viganò, Andrea Palermo, Alessandra Zilli, Pietro Invernizzi, Silvio Danese. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks. Inflammatory Bowel Diseases 2023; 29(9): 1477 doi: 10.1093/ibd/izac189
|